Archived grant — no longer open
This grant has closed and is kept as a historical reference. Browse current grants for active opportunities.
SynthoPlate: Intravenous Hemostatic Nanotechnology to Mitigate Bleeding in Thrombocytopenia
Applications closed.
Description preview
Project Summary/Abstract
The normal platelet count in human blood is 150,000-400,000/μL, and these platelets are responsible for efficient
hemostatic surveillance and bleeding mitigation in the body. Thrombocytopenia (TCP, low platelet count) is a
condition caused by a decrease in platelet production, increase in platelet destruction or…
Full details available on the Agency plan
Unlock the complete grant description, eligibility criteria, contract value, evaluation details and apply link — plus alerts, pipeline tracking, and CSV export.
Agency Plan
7-day free trialUnlock procurement & grants
Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.
$29.99 / month
- 🔔Email alerts for new matching tenders
- 🗂️Track tenders in your pipeline
- 💰Filter by contract value
- 📥Export results to CSV
- 📌Save searches with one click